Subocclusion of the sinus node artery during coronary angioplasty: arrhythmological considerations

Flavio D'Ascenzi1, Alessandro Iadanza, Valerio Zacà

  • 1Cardiologia Universitaria, Azienda Ospedaliera Universitaria Senese, Siena, Italy. flavio.dascenzi@libero.it

Clinical Cardiology
|July 20, 2010
PubMed

Insights

A heart stent procedure caused a blocked artery, leading to atrial fibrillation in a 58-year-old man. This suggests that reduced blood flow can cause sinus node dysfunction and irregular heart rhythms.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia.
  • Sinus node dysfunction (SND) can cause arrhythmias.
  • Coronary artery disease requiring intervention is prevalent.

Observation:

  • A 58-year-old male patient developed new-onset atrial fibrillation.
  • The arrhythmia occurred during percutaneous coronary intervention (PCI) of the left circumflex artery (LCx).
  • The patient had a diseased sinus node artery originating from the LCx.

Findings:

  • Iatrogenic subocclusion of the sinus node artery occurred during LCx stenting.
  • This subocclusion is the likely cause of the patient's sinus node dysfunction.
  • The findings suggest an ischemic etiology for the observed SND.

Implications:

  • Coronary artery interventions carry risks of iatrogenic complications affecting cardiac conduction.
  • Careful attention to the sinus node artery during LCx procedures is crucial.
  • Understanding ischemic causes of SND can inform patient management and procedural techniques.

Related Concept Videos

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Node Analysis for AC Circuits01:14

Node Analysis for AC Circuits

Consider an angioplasty system featuring a catheter equipped with a turbine, a critical tool for removing plaque deposits from coronary arteries. This intricate medical device operates using a circuit model reminiscent of a dual-node RLC circuit powered by a current-controlled voltage source.
To unravel the complexities of this system, nodal analysis is employed, a powerful technique founded on Kirchhoff's current law (KCL), which remains valid for phasors. AC circuits can effectively be...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...